Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 149 participants.
Also called NCT07222813
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 149 participants
- Sponsor
- Registry
-
NCT07222813
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, France, Germany, Poland
- Registry status
- Recruiting
Technical summary
Registry record NCT07222813. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-04-23 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
- Condition
- Heart Failure
- Condition
- Heart Failure - NYHA II - IV
- Intervention (Device)
- FibroScan
- Intervention (Procedure)
- Right-sided Heart Catheterization
- Intervention (Procedure)
- Transthoracic echocardiography
- Intervention (Biological)
- Blood Sample Analysis
- Lead sponsor
- Echosens
- Collaborator
- Syneos Health
Record details
- Record id
cardio:ct-nct07222813- Content hash
c434ffec67fdc65db88da77625a7707820f60614420cf8e1bf9e751489c2eb45